Raia Drogasil S.A.
RADLY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.56 | 7.24 | 1.28 | 0.99 |
| FCF Yield | 1.89% | -0.65% | 1.22% | 1.63% |
| EV / EBITDA | 12.86 | 21.55 | 18.83 | 17.99 |
| Quality | ||||
| ROIC | 13.94% | 13.79% | 10.70% | 9.28% |
| Gross Margin | 29.72% | 30.04% | 30.31% | 29.87% |
| Cash Conversion Ratio | 1.50 | 0.73 | 1.41 | 1.57 |
| Growth | ||||
| Revenue 3-Year CAGR | 10.17% | 12.08% | 13.15% | 11.16% |
| Free Cash Flow Growth | 283.87% | -169.31% | -28.99% | -13.22% |
| Safety | ||||
| Net Debt / EBITDA | 2.28 | 2.42 | 2.29 | 1.83 |
| Interest Coverage | 2.91 | 2.82 | 5.06 | 5.36 |
| Efficiency | ||||
| Inventory Turnover | 3.25 | 3.30 | 3.31 | 3.31 |
| Cash Conversion Cycle | 60.08 | 65.97 | 62.35 | 57.39 |